Literature DB >> 19331454

Conditioned stimulus familiarity determines effects of MK-801 on fear extinction.

Wan Yee Macy Chan1, Gavan P McNally.   

Abstract

Six experiments studied the role of conditioned stimulus (CS) familiarity in determining the effects of the N-methyl-d-aspartate (NMDA) receptor antagonist MK-801 on fear extinction. Systemic administration of MK-801 (0.1 mg/kg) impaired initial extinction but not reextinction learning. MK-801 impaired reextinction learning when the CS was relatively novel during reextinction training but not initial extinction learning when the CS was relatively familiar during initial extinction training. A context change failed to reinstate the sensitivity of initial fear extinction learning about a relatively familiar CS to MK-801. These experiments show that CS familiarity is an important determinant of effects of MK-801 on fear extinction learning: MK-801 impaired extinction learning about novel stimuli but spared extinction learning about familiar stimuli. (c) 2009 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331454     DOI: 10.1037/a0014988

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  14 in total

Review 1.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

2.  Acute, but not chronic, exposure to d-cycloserine facilitates extinction and modulates spontaneous recovery of a conditioned taste aversion.

Authors:  G Andrew Mickley; Jennifer L Remus; Linnet Ramos; Gina N Wilson; Orion R Biesan; Kyle D Ketchesin
Journal:  Physiol Behav       Date:  2011-09-10

3.  Dopamine-mediated MK-801-induced elevation in food-based extinction responding in rats and associated changes in region-specific phosphorylated ERK.

Authors:  Matthew R Holahan; Melanie J Clarke; Delaney D Hines
Journal:  Psychopharmacology (Berl)       Date:  2010-07-23       Impact factor: 4.530

Review 4.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

Review 5.  Glutamate receptors in extinction and extinction-based therapies for psychiatric illness.

Authors:  Karyn M Myers; William A Carlezon; Michael Davis
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

6.  Glucocorticoid receptor antagonism disrupts the reconsolidation of social reward-related memories in rats.

Authors:  E J Marijke Achterberg; Viviana Trezza; Louk J M J Vanderschuren
Journal:  Behav Pharmacol       Date:  2014-06       Impact factor: 2.293

Review 7.  Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

Review 8.  Animal models of serotonergic psychedelics.

Authors:  James B Hanks; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2012-09-24       Impact factor: 4.418

9.  Characterization of NMDAR-Independent Learning in the Hippocampus.

Authors:  Kaycie Kuss Tayler; Elizabeth Lowry; Kazumasa Tanaka; Brynne Levy; Leon Reijmers; Mark Mayford; Brian J Wiltgen
Journal:  Front Behav Neurosci       Date:  2011-05-18       Impact factor: 3.558

Review 10.  NMDA receptors and fear extinction: implications for cognitive behavioral therapy.

Authors:  Michael Davis
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.